Explore

Rapid Read Rapid Read
French Broad Chocolates Recalls Bonbons Due to Undeclared Walnuts Affecting 40 States

French Broad Chocolates Recalls Bonbons Due to Undeclared Walnuts Affecting 40 States

French Broad Chocolates PBC, a North Carolina-based chocolate manufacturer, has issued a recall for its Bette's Bake Sale Bonbon Collections due to undeclared walnuts. The recall affects 6-, 12-, and 24-piece boxes of bonbons, which were sold between April 14-20, 2026. The issue arose from a labeling error where the labels for Walnut Fudge and Peach Cobbler bonbons were switched, potentially leading to serious allergic reactions for individuals with walnut allergies. The affected products have batch numbers '260414' and '260417' and were distributed in 40 states, including major markets like California, New York, and Texas. No illnesses have been reported so far. Consumers are advised to discard the chocolates or return them for a full refund.
Trendline Trendline
Berlin Heals' CMIC-III Study Shows Promising Results for Heart Failure Treatment

Berlin Heals' CMIC-III Study Shows Promising Results for Heart Failure Treatment

Berlin Heals' CMIC-III Study Shows Promising Results for Heart Failure Treatment
Rapid Read Rapid Read
AI's Role in Medicine: Balancing Innovation with Regulation

AI's Role in Medicine: Balancing Innovation with Regulation

A recent opinion piece highlights the transformative potential of artificial intelligence (AI) in democratizing healthcare access, particularly for underserved patients. The article discusses the rapid integration of AI in medical practices, where AI tools are increasingly used for routine prescriptions and minor medical conditions. However, the piece emphasizes the urgent need for robust regulation to ensure patient safety, as AI's role in medicine continues to expand. States like New York and California are taking different regulatory approaches, with New York considering legislation that could restrict AI's medical applications, while California mandates disclosure when AI is involved in patient care. The federal government is also involved, with the FDA updating its guidelines to allow certain AI tools to operate with less oversight when assisting doctors.
Rapid Read Rapid Read
Gene Therapy Leaders Push for Novel Regulatory Models to Aid Rare Disease Treatments

Gene Therapy Leaders Push for Novel Regulatory Models to Aid Rare Disease Treatments

Gene therapy leaders are advocating for new regulatory models to facilitate the development of personalized treatments for rare diseases. This push comes nearly a year after Baby KJ Muldoon received a groundbreaking CRISPR treatment for CPS1 deficiency, a rare genetic condition. The Innovative Genomics Institute, led by CRISPR pioneer Jennifer Doudna, is preparing to trial a similar treatment for another child with a different genetic disorder. The FDA's plausible mechanism pathway aims to accelerate gene therapies for small patient populations, but some in the biotech industry, like EveryONE Medicines, have found it insufficient for commercial viability. The pathway requires separate applications for each drug, which can be burdensome. Biopharma companies, including Aurora Therapeutics, are working to develop platform technologies to streamline the production of gene therapies for rare mutations.
Rapid Read Rapid Read
Mount Soledad Memorial Honors Medal of Honor Recipient Master Sgt. John Chapman

Mount Soledad Memorial Honors Medal of Honor Recipient Master Sgt. John Chapman

Master Sgt. John 'Chappy' Chapman, an Air Force hero, was honored with a plaque at the Mount Soledad National Veterans Memorial in San Diego, California. Chapman was posthumously awarded the Medal of Honor in 2018 for his bravery during the Battle of Takur Ghar in Afghanistan on March 4, 2002. During the battle, Chapman was part of a Navy SEAL team and was initially left for dead after being wounded. However, he regained consciousness and continued to fight the enemy alone, ultimately sacrificing his life. His actions saved the lives of many, including 18 men on a helicopter he did not know. The plaque, carved from black granite, stands as a testament to his heroism and dedication to his fellow soldiers.
Rapid Read Rapid Read
FDA Approves AstraZeneca's Saphnelo Pen for Self-Administration in Lupus Patients

FDA Approves AstraZeneca's Saphnelo Pen for Self-Administration in Lupus Patients

The U.S. Food and Drug Administration (FDA) has approved AstraZeneca's Saphnelo (anifrolumab) for self-administration as a once-weekly autoinjector, known as the Saphnelo Pen, for adult patients with systemic lupus erythematosus (SLE). This approval is based on the results from the Phase III TULIP-SC trial, which demonstrated a significant reduction in disease activity for patients with moderate to severe SLE. The trial results, published in Arthritis & Rheumatology, showed that the subcutaneous administration of Saphnelo was both statistically significant and clinically meaningful compared to a placebo. The safety profile of the autoinjector was consistent with the known clinical profile of Saphnelo when administered intravenously. This development is seen as a major advancement in the treatment of lupus, offering patients a more convenient and accessible option.
SB Nation SB Nation
Friars reportedly in on top free agent in upcoming class

Friars reportedly in on top free agent in upcoming class

New ownership in San Diego makes way for all kinds of possibilities
Trendline Trendline
Jonah Hill Relocates Family to San Diego for a Quieter Life

Jonah Hill Relocates Family to San Diego for a Quieter Life

Jonah Hill Relocates Family to San Diego for a Quieter Life
Rapid Read Rapid Read
AI's Potential to Transform Medicine Hinges on Regulatory Frameworks

AI's Potential to Transform Medicine Hinges on Regulatory Frameworks

Artificial intelligence (AI) is increasingly being used in medicine, with one in three Americans turning to AI chatbots for medical advice. However, the lack of consistent regulation poses challenges. Some states, like New York, are considering strict regulations, while others, like California, are taking a more balanced approach. The federal government is also involved, with the FDA updating guidelines to allow AI tools to assist doctors with less oversight. The potential of AI to democratize access to healthcare is significant, but it requires robust regulatory frameworks to ensure safety and effectiveness.
Rapid Read Rapid Read
Ophirex Develops Potential Lifesaving Anti-Venom Pill Amid Rising Snakebite Fatalities

Ophirex Develops Potential Lifesaving Anti-Venom Pill Amid Rising Snakebite Fatalities

Ophirex, a Bay Area-based public benefit corporation, is advancing the development of an anti-venom pill named Varespladib, which could significantly improve survival rates for snakebite victims. This development comes in response to a notable increase in snakebite fatalities in California, where three deaths have been reported in just two months. The Centers for Disease Control and Prevention typically reports an average of five snakebite deaths annually across the United States. Varespladib works by neutralizing a key toxin present in 95% of snake species and is intended to be used alongside hospital-administered anti-venom treatments. The pill is particularly effective against common North American snakes, including several rattlesnake species and the Copperhead. Ophirex aims to secure FDA approval for human and canine use by late next year, with the goal of making the treatment accessible to backpackers and emergency personnel.
Rapid Read Rapid Read
FDA Approves Gene Therapy for Genetic Hearing Loss, Offering Free Treatment

FDA Approves Gene Therapy for Genetic Hearing Loss, Offering Free Treatment

The Food and Drug Administration (FDA) has approved Otarmeni, a gene therapy developed by Regeneron, for a rare form of inherited hearing loss. This therapy targets children and adults with OTOF-related deafness, a condition caused by a mutation in the OTOF gene, which is crucial for hearing. The approval follows a clinical trial involving 20 children, where 16 showed hearing improvement after receiving the therapy. The treatment, which involves a single injection into the cochlea, is reported to be generally safe with no major side effects. Regeneron has announced that the therapy will be provided free of charge to U.S. patients, highlighting the company's commitment to making biopharmaceutical advancements accessible.
Rapid Read Rapid Read
Doctors Warn Against DIY Peptide Injections Amid Rising Health Concerns

Doctors Warn Against DIY Peptide Injections Amid Rising Health Concerns

Doctors are increasingly alarmed by the rising trend of individuals using injectable peptides for weight loss, muscle gain, and anti-aging purposes without proper medical supervision. Peptides, which are short chains of amino acids, are being used by some as a quick fix for various health and aesthetic goals. However, many of these substances are not approved for human use and are often sourced from unregulated online markets. This has led to a surge in health complications, including severe allergic reactions, hormonal imbalances, and insulin resistance. Medical professionals are particularly concerned about the lack of rigorous human studies on these peptides and the potential for serious side effects when used improperly.